High Risk of Death or Disability in Brain Hemorrhage: Role of Spot Sign and Secondary Markers
Condition(s) studied
Study summary
This study looks at patients with brain hemorrhage to see if a special sign on brain scans, called the "Spot Sign," combined with other scan features, can predict a higher risk of death or disability. By comparing patient outcomes with existing prediction scores, the study aims to understand whether these scan markers provide extra value in identifying patients at higher risk.
Eligibility
Primary outcome measure(s)
- Hematoma Expansion within 48 Hours: Increase of more than 6 mL or over 30% between the initial CT and the follow-up CT (PREDICT study criterion) and/or Occurrence of Death Within the First Month — 48 hours
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| Centre Hospitalier de Gonesse | Gonesse | France |
More Centre Hospitalier de Gonesse trials in France
Other trials for the same condition
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT07172542 on ClinicalTrials.gov ↗ ← All trials in France